Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity.
Kinders
Robert J
RJ
Laboratory of Human Toxicology and Pharmacology, Applied/Developmental Research Support Directorate, Science Applications International Corporation-Frederick, Inc., NationalCancer Institute-Frederick, Frederick, MD 21702, USA. kindersr@mail.nih.gov
Hollingshead
Melinda
M
Lawrence
Scott
S
Ji
Jiuping
J
Tabb
Brian
B
Bonner
William M
WM
Pommier
Yves
Y
Rubinstein
Larry
L
Evrard
Yvonne A
YA
Parchment
Ralph E
RE
Tomaszewski
Joseph
J
Doroshow
James H
JH